scholarly journals Obese diet-induced mouse models of nonalcoholic steatohepatitis-tracking disease by liver biopsy

2016 ◽  
Vol 8 (16) ◽  
pp. 673 ◽  
Author(s):  
Maria Nicoline Baandrup Kristiansen ◽  
Sanne Skovgård Veidal ◽  
Kristoffer Tobias Gustav Rigbolt ◽  
Kirstine Sloth Tølbøl ◽  
Jonathan David Roth ◽  
...  
2018 ◽  
Vol 88 (5-6) ◽  
pp. 263-269
Author(s):  
Seong-Hoon Park ◽  
A Lum Han ◽  
Na-Hyung Kim ◽  
Sae-Ron Shin

Abstract. Background: Vitamin C is a strong antioxidant, and the health effects of vitamin C megadoses have not been validated despite the apparent health benefits. Therefore, the present study sought to confirm the effects of vitamin C megadoses. Materials and Methods : Four groups of six guinea pigs were used. Each group was fed one of the following diets for three weeks: normal diet, methionine choline-deficient diet, methionine choline-deficient diet + vitamin C megadose (MCD + vit C 2.5 g/kg/day), and methionine-choline deficient diet + ursodeoxycholic acid (MCD + UDCA 30 mg/kg/day). The MCD diet was given to induce nonalcoholic steatohepatitis, and UDCA was used to treat nonalcoholic steatohepatitis. Three weeks after initial diet administration, the results of biochemical tests and liver biopsy were compared between the groups. Results: The cytoplasm state was similar in the MCD + vit C and MCD + UDCA groups, exhibiting clearing of the cytoplasm and ballooning degeneration. However, macrovesicular steatosis was not observed in the MCD + vit C group. Aspartate transaminase and alanine transaminase were elevated significantly following vitamin C administration. Conclusions: The present study confirmed that alone vitamin C megadoses are potential remedies for nonalcoholic steatohepatitis, based on the liver biopsy results of guinea pigs that were unable to synthesize vitamin C.


Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 2020-P
Author(s):  
BRANDON B. BOLAND ◽  
HENRIK H. HANSEN ◽  
MICHELLE BOLAND ◽  
DENISE ORÓ ◽  
KIRSTINE SLOTH TØLBØL ◽  
...  

2016 ◽  
Vol 6 (2) ◽  
pp. 185-200 ◽  
Author(s):  
Ans Jacobs ◽  
Anne‐Sophie Warda ◽  
Jef Verbeek ◽  
David Cassiman ◽  
Pieter Spincemaille

2020 ◽  
Vol 2020 ◽  
pp. 1-12
Author(s):  
Andreas Kroh ◽  
Vanina Ivanova ◽  
Hannah Drescher ◽  
Julia Andruszkow ◽  
Thomas Longerich ◽  
...  

A variety of dietary nonalcoholic steatohepatitis (NASH) mouse models are available, and choosing the appropriate mouse model is one of the most important steps in the design of NASH studies. In addition to the histopathological and metabolic findings of NASH, a sufficient mouse model should guarantee a robust clinical status and good animal welfare. Three different NASH diets, a high-fat diet (HFD60), a western diet (WD), and a cafeteria diet (CAFD), were fed for 12 or 16 weeks. Metabolic assessment was conducted at baseline and before scheduled sacrifice, and liver inflammation was analyzed via fluorescence-associated cell sorting and histopathological examination. Clinical health conditions were scored weekly to assess the impact on animal welfare. The HFD60 and WD were identified as suitable NASH mouse models without a significant strain on animal welfare. Furthermore, the progression of inflammation and liver fibrosis was associated with a decreased proportion of CD3+ NK1.1+ cells. The WD represents a model of advanced-stage NASH, and the HFD60 is a strong model of nonalcoholic fatty liver disease (NAFLD) and metabolic syndrome. However, the CAFD should not be considered a NASH model.


2000 ◽  
Vol 14 (4) ◽  
pp. 321-326 ◽  
Author(s):  
Brent A Neuschwander-Tetri

Nonalcoholic steatohepatitis (NASH) is a histological diagnosis applied to a constellation of liver biopsy findings that develop in the absence of alcohol abuse. Steatosis, a mixed cellular inflammatory infiltrate across the lobule, evidence of hepatocyte injury and fibrosis are the findings that can be seen. This entity is often identified during evaluation of elevated aminotransferases after exclusion of viral, metabolic and other causes of liver disease. Obesity is a major risk factor for NASH. The role of diabetes is less certain, although evidence is accumulating that hyperinsulinism may play an important pathophysiological role. Patients sometimes suffer from right upper quadrant abdominal pain and fatigue; examination may reveal centripetal obesity and hepatomegaly. Although patients are often discovered because of persistent aminotransferase elevations, these enzymes can be normal in NASH. When they are elevated, the alanine aminotransferase level is typically significantly greater than the aspartate aminotransferase level. This can be particularly helpful for excluding occult alcohol abuse. Imaging studies identify hepatic steatosis when the amount of fat in the liver is significant; however, imaging does not distinguish benign steatosis from NASH. Ultimately a liver biopsy is needed to diagnose NASH. The biopsy may be useful for establishing prognosis based on the presence or absence of fibrosis and for excluding other unexpected causes of liver enzyme elevations. Weight loss is the mainstay of treatment for obese patients. About 15% to 40% of NASH patients develop fibrosis; how many of these cases progress to cirrhosis is unknown, but about 1% of liver transplants are performed with a pretransplant diagnosis of NASH.


PLoS ONE ◽  
2015 ◽  
Vol 10 (5) ◽  
pp. e0127991 ◽  
Author(s):  
Mariana Verdelho Machado ◽  
Gregory Alexander Michelotti ◽  
Guanhua Xie ◽  
Thiago Pereira de Almeida ◽  
Jerome Boursier ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document